South Africa moves to substantive examination for pharma patents, amid fears system could grind to halt
New IP policy looks to get tough on evergreening in pharma industry but also brings country closer to international best practices.
To read more
Register for limited access
Register to receive our newsletter and gain limited access to subscriber content.
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the IAM experts.